Apoptosis in the skeletal muscle of patients with heart failure: investigation of clinical and biochemical changes

OBJECTIVE To investigate the contribution of apoptosis in the development of the skeletal myopathy in chronic heart failure. DESIGN The electrophoretic pattern of myosin heavy chains (MHC), fibre cross sectional area, number of in situ nick end labelling (TUNEL) positive apoptotic myocyte nuclei, and the tissue levels of caspase-3, Bcl-2, and ubiquitin were determined in biopsies taken from the vastus lateralis muscle. The study involved nine patients with severe chronic heart failure caused by ischaemic heart disease and hibernating myocardium and five controls. RESULTS In chronic heart failure patients the vastus lateralis showed a significant increase of MHC2a and MHC2b and a greater degree of fibre atrophy, as demonstrated by the decreased cross sectional area. There was also an increased number of TUNEL positive apoptotic myocyte nuclei. Tissue concentrations of Bcl-2 were decreased, while those of caspase-3 and ubiquitin were increased. Peak oxygen consumption (Vo 2) was negatively correlated with the number of TUNEL positive nuclei and the fibre cross sectional area. There was a correlation between the number of apoptotic nuclei and the fibre cross sectional area, but no correlation between myosin heavy chains and number of apoptotic nuclei. CONCLUSIONS Myocyte apoptosis occurs in the skeletal muscle of patients with chronic heart failure, and its magnitude is associated with the severity of exercise capacity limitation and the degree of muscle atrophy. Muscle atrophy contributes to the limitation of exercise capacity, together with the increased synthesis of fast, more fatiguable myosin heavy chains.

[1]  M. Sandri,et al.  Apoptosis of skeletal muscle myofibers and interstitial cells in experimental heart failure. , 1998, Journal of molecular and cellular cardiology.

[2]  R. Virmani,et al.  Apoptosis in myocytes in end-stage heart failure. , 1996, The New England journal of medicine.

[3]  R. Lenkinski,et al.  Contribution of Skeletal Muscle Atrophy to Exercise Intolerance and Altered Muscle Metabolism in Heart Failure , 1992, Circulation.

[4]  Gerald B. Stringfellow,et al.  Organometallic vapor‐phase epitaxial growth and characterization of the metastable alloy InP1−xSbx , 1988 .

[5]  R J Shephard,et al.  Muscle mass as a factor limiting physical work. , 1988, Journal of applied physiology.

[6]  B. Chance,et al.  Abnormal skeletal muscle bioenergetics during exercise in patients with heart failure: role of reduced muscle blood flow. , 1986, Circulation.

[7]  H. Steller.  Mechanisms and genes of cellular suicide , 1995, Science.

[8]  B. Massie,et al.  Neurophysiological Assessment of Skeletal Muscle Fatigue in Patients With Congestive Heart Failure , 1992, Circulation.

[9]  G. Radda,et al.  Skeletal muscle metabolism in heart failure: a 31P nuclear magnetic resonance spectroscopy study of leg muscle. , 1990, Clinical science.

[10]  J. S. Janicki,et al.  Exercise testing in the evaluation of the patient with chronic cardiac failure. , 2015, The American review of respiratory disease.

[11]  M. Volterrani,et al.  Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition. , 1998, Circulation.

[12]  C. Leprotti,et al.  Skeletal muscle myosin heavy chains in heart failure: correlation between magnitude of the isozyme shift, exercise capacity, and gas exchange measurements. , 1998, American heart journal.

[13]  M. Sandri,et al.  Apoptosis and atrophy in rat slow skeletal muscles in chronic heart failure. , 1999, American journal of physiology. Cell physiology.

[14]  F. Cobb,et al.  Skeletal muscle biochemistry and histology in ambulatory patients with long-term heart failure. , 1990, Circulation.

[15]  Prof. Dr. Johann Caspar Rüegg.  Calcium in Muscle Contraction , 1992, Springer Berlin Heidelberg.

[16]  C. Catani,et al.  Specific changes in skeletal muscle myosin heavy chain composition in cardiac failure: differences compared with disuse atrophy as assessed on microbiopsies by high resolution electrophoresis. , 1996, Heart.

[17]  M. Piepoli,et al.  Predictors of exercise capacity in chronic heart failure. , 1994, European heart journal.

[18]  P. Poole‐Wilson,et al.  Symptoms and quality of life in heart failure: the muscle hypothesis. , 1994, British heart journal.

[19]  B. Chance,et al.  Evaluation of energy metabolism in skeletal muscle of patients with heart failure with gated phosphorus-31 nuclear magnetic resonance. , 1985, Circulation.

[20]  G. Schuler,et al.  Apoptosis in skeletal myocytes of patients with chronic heart failure is associated with exercise intolerance. , 1999, Journal of the American College of Cardiology.

[21]  H. Goebel,et al.  DNA‐fragmentation and expression of apoptosis‐related proteins in experimentally denervated and reinnervated rat facial muscle , 1997, Neuropathology and applied neurobiology.

[22]  C. Long,et al.  Heart failure in rats causes changes in skeletal muscle morphology and gene expression that are not explained by reduced activity. , 1996, Circulation research.

[23]  M. Sandri,et al.  Apoptosis, DNA damage and ubiquitin expression in normal and mdx muscle fibers after exercise , 1995, FEBS letters.

[24]  G. Thiene,et al.  Correlation between endomyocardial biopsies and ventricle full-thickness samples in dilated cardiomyopathy: A study of myocytes and fibrosis. , 1994, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[25]  P. Poole‐Wilson,et al.  Abnormalities of skeletal muscle in patients with chronic heart failure. , 1988, International journal of cardiology.

[26]  M. Sandri,et al.  Exercise Induces Myonuclear Ubiquitination and Apoptosis in Dystrophin‐deficient Muscle of Mice , 1997, Journal of neuropathology and experimental neurology.

[27]  N. Agell,et al.  TNF can directly induce the expression of ubiquitin-dependent proteolytic system in rat soleus muscles. , 1997, Biochemical and biophysical research communications.

[28]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[29]  C A Beltrami,et al.  Apoptosis in the failing human heart. , 1997, The New England journal of medicine.

[30]  S. Harridge,et al.  Skeletal muscle contractile characteristics and fatigue resistance in patients with chronic heart failure. , 1996, European heart journal.

[31]  L. Fink,et al.  Exercise ventilation and pulmonary artery wedge pressure in chronic stable congestive heart failure. , 1986, The American journal of cardiology.

[32]  J. Fleg,et al.  Role of muscle loss in the age-associated reduction in VO2 max. , 1988, Journal of applied physiology.

[33]  R E Grindeland,et al.  Apoptosis: a mechanism contributing to remodeling of skeletal muscle in response to hindlimb unweighting. , 1997, The American journal of physiology.

[34]  R. Ferrari,et al.  Skeletal muscle myosin heavy chain expression in rats with monocrotaline-induced cardiac hypertrophy and failure. Relation to blood flow and degree of muscle atrophy. , 1998, Cardiovascular research.

[35]  P. Ponikowski,et al.  Skeletal muscle function and its relation to exercise tolerance in chronic heart failure. , 1997, Journal of the American College of Cardiology.

[36]  P. Poole‐Wilson,et al.  The influence of muscle mass, strength, fatigability and blood flow on exercise capacity in cachectic and non-cachectic patients with chronic heart failure. , 1997, European heart journal.

[37]  C. Catani,et al.  A sensitive SDS-PAGE method separating myosin heavy chain isoforms of rat skeletal muscles reveals the heterogeneous nature of the embryonic myosin. , 1983, Biochemical and biophysical research communications.

[38]  T. Levine,et al.  Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure. , 1981, The American journal of cardiology.

[39]  S. Frostick,et al.  Skeletal muscle metabolism during exercise under ischemic conditions in congestive heart failure. Evidence for abnormalities unrelated to blood flow. , 1988, Circulation.

[40]  S. Anker,et al.  Cachexia in heart failure is bad for you. , 1998, European heart journal.

[41]  B. Chance,et al.  Detection of abnormal calf muscle metabolism in patients with heart failure using phosphorus-31 nuclear magnetic resonance. , 1988, The American journal of cardiology.